SHL will be exhibiting at the 2011 Parental Drug Association (PDA) Europe Conference in Basel, Switzerland November 8-9^th at booth #44 & 49. SHL Medical Europe's Vice President, Mats Persson and SHL Group’s Marketing Director, Steven Kaufman have been invited to present at this annual event as keynote speakers on the topic of “Insight into Development and Manufacturing of Auto Injectors.”

There will be more than 500 attendees and 80 exhibitors at this year’s “The Universe of Pre-filled Syringes and Injection Devices” event. The overall focus of this year’s conference will be on Device Usability and Compliance with speaking sessions divided into more specific areas such as daily user experiences, regulatory matters, device design factors, manufacturing and more. In addition to sharing SHL’s experience with the audience about how to develop and manufacture auto injectors on the opening day, SHL’s staff at the exhibition booth will give visitors the opportunity to have hands-on demonstrations of the company’s latest drug delivery devices.

Commenting on this event, Marketing Director Steven Kaufman says, “The auto injector market is growing rapidly and along with increasing opportunities comes challenges that many have not anticipated. It is therefore vital that conferences like this take place as it brings together experts from different backgrounds and stimulates knowledge exchanges to better support growing industry demands. We will also be arranging private meetings at the request of biopharmaceutical customers and potential customers to give them time to speak with the staff we will be sending to this event.”

About SHL

SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,800 staff globally (1000+ staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.

SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.

Our organization consists of three distinct group companies:

SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies

SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use

SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products

For additional information visit www.shl-group.com or contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it